Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment
Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.